267 related articles for article (PubMed ID: 24994841)
1. Outcome after surgical or conservative management of cerebral cavernous malformations.
Moultrie F; Horne MA; Josephson CB; Hall JM; Counsell CE; Bhattacharya JJ; Papanastassiou V; Sellar RJ; Warlow CP; Murray GD; Al-Shahi Salman R;
Neurology; 2014 Aug; 83(7):582-9. PubMed ID: 24994841
[TBL] [Abstract][Full Text] [Related]
2. Association Between Beta-Blocker or Statin Drug Use and the Risk of Hemorrhage From Cerebral Cavernous Malformations.
Zuurbier SM; Hickman CR; Rinkel LA; Berg R; Sure U; Al-Shahi Salman R;
Stroke; 2022 Aug; 53(8):2521-2527. PubMed ID: 35410492
[TBL] [Abstract][Full Text] [Related]
3. Radiosurgical, neurosurgical, or no intervention for cerebral cavernous malformations: A decision analysis.
Rinkel LA; Al-Shahi Salman R; Rinkel GJ; Greving JP
Int J Stroke; 2019 Dec; 14(9):939-945. PubMed ID: 31122172
[TBL] [Abstract][Full Text] [Related]
4. Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis.
Zuurbier SM; Hickman CR; Tolias CS; Rinkel LA; Leyrer R; Flemming KD; Bervini D; Lanzino G; Wityk RJ; Schneble HM; Sure U; Al-Shahi Salman R;
Lancet Neurol; 2019 Oct; 18(10):935-941. PubMed ID: 31401075
[TBL] [Abstract][Full Text] [Related]
5. Morbidity After Symptomatic Hemorrhage of Cerebral Cavernous Malformation: A Nomogram Approach to Risk Assessment.
Ma L; Zhang S; Li Z; Wu CX; Wang Z; Zhan L; Hao Q; Wang H; Ye X; Chen X; Liu YO; Wang S; Zhao YL
Stroke; 2020 Oct; 51(10):2997-3006. PubMed ID: 32951540
[TBL] [Abstract][Full Text] [Related]
6. Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study.
Al-Shahi Salman R; Hall JM; Horne MA; Moultrie F; Josephson CB; Bhattacharya JJ; Counsell CE; Murray GD; Papanastassiou V; Ritchie V; Roberts RC; Sellar RJ; Warlow CP;
Lancet Neurol; 2012 Mar; 11(3):217-24. PubMed ID: 22297119
[TBL] [Abstract][Full Text] [Related]
7. Female Hormone Therapy and Risk of Intracranial Hemorrhage From Cerebral Cavernous Malformations: A Multicenter Observational Cohort Study.
Zuurbier SM; Santos AN; Flemming KD; Schmidt B; Jabbarli R; Lanzino G; Sure U; Dammann P
Neurology; 2023 Apr; 100(16):e1673-e1679. PubMed ID: 36754635
[TBL] [Abstract][Full Text] [Related]
8. Solitary Sporadic Cerebral Cavernous Malformations: Risk Factors of First or Recurrent Symptomatic Hemorrhage and Associated Functional Impairment.
Dammann P; Jabbarli R; Wittek P; Oppong MD; Kneist A; Zhu Y; Wrede K; Müller O; Forsting M; Sure U
World Neurosurg; 2016 Jul; 91():73-80. PubMed ID: 27058610
[TBL] [Abstract][Full Text] [Related]
9. Intracranial Hemorrhage Rate and Lesion Burden in Patients With Familial Cerebral Cavernous Malformation.
Weinsheimer S; Nelson J; Abla AA; Ko NU; Tsang C; Okoye O; Zabramski JM; Akers A; Zafar A; Mabray MC; Hart BL; Morrison L; McCulloch CE; Kim H;
J Am Heart Assoc; 2023 Feb; 12(3):e027572. PubMed ID: 36695309
[TBL] [Abstract][Full Text] [Related]
10. Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data.
Horne MA; Flemming KD; Su IC; Stapf C; Jeon JP; Li D; Maxwell SS; White P; Christianson TJ; Agid R; Cho WS; Oh CW; Wu Z; Zhang JT; Kim JE; Ter Brugge K; Willinsky R; Brown RD; Murray GD; Al-Shahi Salman R;
Lancet Neurol; 2016 Feb; 15(2):166-173. PubMed ID: 26654287
[TBL] [Abstract][Full Text] [Related]
11. Rebleeding and Outcome in Patients with Symptomatic Brain Stem Cavernomas.
Arauz A; Patiño-Rodriguez HM; Chavarria-Medina M; Becerril M; Longo GM; Nathal E
Cerebrovasc Dis; 2017; 43(5-6):283-289. PubMed ID: 28319946
[TBL] [Abstract][Full Text] [Related]
12. Predictors of future haemorrhage from cerebral cavernous malformations: a retrospective cohort study.
Gillespie CS; Alnaham KE; Richardson GE; Mustafa MA; Taweel BA; Islim AI; Hannan CJ; Chavredakis E
Neurosurg Rev; 2023 Feb; 46(1):52. PubMed ID: 36763222
[TBL] [Abstract][Full Text] [Related]
13. Outcome after conservative management or intervention for unruptured brain arteriovenous malformations.
Al-Shahi Salman R; White PM; Counsell CE; du Plessis J; van Beijnum J; Josephson CB; Wilkinson T; Wedderburn CJ; Chandy Z; St George EJ; Sellar RJ; Warlow CP;
JAMA; 2014 Apr 23-30; 311(16):1661-9. PubMed ID: 24756516
[TBL] [Abstract][Full Text] [Related]
14. Hemorrhage from cerebral cavernous malformations: The role of associated developmental venous anomalies.
Chen B; Herten A; Saban D; Rauscher S; Radbruch A; Schmidt B; Zhu Y; Jabbarli R; Wrede KH; Kleinschnitz C; Sure U; Dammann P
Neurology; 2020 Jul; 95(1):e89-e96. PubMed ID: 32513786
[TBL] [Abstract][Full Text] [Related]
15. Clinical course of untreated thalamic cavernous malformations: hemorrhage risk and neurological outcomes.
Tian KB; Zheng JJ; Ma JP; Hao SY; Wang L; Zhang LW; Wu Z; Zhang JT; Li D
J Neurosurg; 2017 Sep; 127(3):480-491. PubMed ID: 27834594
[TBL] [Abstract][Full Text] [Related]
16. Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial.
Lanfranconi S; Scola E; Bertani GA; Zarino B; Pallini R; d'Alessandris G; Mazzon E; Marino S; Carriero MR; Scelzo E; Faragò G; Castori M; Fusco C; Petracca A; d'Agruma L; Tassi L; d'Orio P; Lampugnani MG; Nicolis EB; Vasamì A; Novelli D; Torri V; Meessen JMTA; Al-Shahi Salman R; Dejana E; Latini R;
Trials; 2020 May; 21(1):401. PubMed ID: 32398113
[TBL] [Abstract][Full Text] [Related]
17. Surgery for cerebral cavernous malformations: a systematic review and meta-analysis.
Harris L; Poorthuis MHF; Grover P; Kitchen N; Al-Shahi Salman R
Neurosurg Rev; 2022 Feb; 45(1):231-241. PubMed ID: 34191202
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic cavernous malformations of the brainstem: functional outcome after microsurgical resection.
Schwartz C; Grillhösl A; Schichor C; Suchorska B; Romagna A; Tonn JC; Zausinger S
J Neurol; 2013 Nov; 260(11):2815-22. PubMed ID: 23974645
[TBL] [Abstract][Full Text] [Related]
19. Natural Course of Cerebral Cavernous Malformations in Children: A Five-Year Follow-Up Study.
Santos AN; Rauschenbach L; Saban D; Chen B; Herten A; Dinger TF; Li Y; Tippelt S; Della Marina A; Dohna-Schwake C; Schmidt B; Jabbarli R; Wrede KH; Sure U; Dammann P
Stroke; 2022 Mar; 53(3):817-824. PubMed ID: 34706565
[TBL] [Abstract][Full Text] [Related]
20. Zabramski classification in predicting the occurrence of symptomatic intracerebral hemorrhage in sporadic cerebral cavernous malformations.
Wang J; Yu QF; Huo R; Sun YF; Jiao YM; Xu HY; Zhang JZ; Zhao SZ; He QH; Wang S; Zhao JZ; Cao Y
J Neurosurg; 2024 Mar; 140(3):792-799. PubMed ID: 37724811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
